Light Mode
$0.4086 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.4086, $0.0102 below the day’s high of $0.4188
-0.29 (-41.63%) / 6M
Momentum, market sentiment, and recent alerts
TNYA reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -75.4%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. Its programs include TN-201, TN-401, and TN-301. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Newell Olson in 2016 and is headquartered in South San Francisco, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.